Adlai Nortye (ANL) Enterprise Value (2022 - 2025)

Adlai Nortye's (ANL) quarterly Enterprise Value came in at -$8.1 million in Q4 2025, up 86.77% year-on-year from -$4.3 million in Q4 2024, and up 81.75% on a QoQ basis from -$44.1 million in Q2 2025.

Adlai Nortye (ANL) Enterprise Value (2022 - 2025) Analysis & Trends

Adlai Nortye (ANL) has 4 years of Enterprise Value data on file, last reported at -$8.1 million in Q4 2025.

  • On a quarterly basis, Enterprise Value rose 86.77% year-over-year to -$8.1 million in Q4 2025; TTM through Dec 2025 was -$8.1 million, a 86.77% increase from a year earlier, with the FY2025 full-year figure at -$8.1 million, up 86.77% from the prior year.
  • Enterprise Value for Q4 2025 stood at -$8.1 million, up from -$44.1 million in the prior quarter.
  • Over the last five years, Enterprise Value for ANL reached as high as -$8.1 million in Q4 2025 and fell as low as -$98.0 million in Q2 2024.
  • Historically, Enterprise Value has averaged -$61.1 million across 4 years, with a median of -$62.5 million in 2022.
  • Across the five-year window, Enterprise Value sank 42.87% in 2023 and soared 86.77% in 2025, its largest moves.
  • Year by year, Enterprise Value stood at -$64.0 million in 2022, then sank by 42.87% to -$91.5 million in 2023, then soared by 33.43% to -$60.9 million in 2024, then surged by 86.77% to -$8.1 million in 2025.
  • Per Business Quant data, the three most recent Enterprise Value figures were -$8.1 million in Q4 2025, -$44.1 million in Q2 2025, and -$60.9 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn - -283.54 Mn
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn - -61.40 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -2.83 Mn
4 BeOne Medicines 472.03 Bn 467.24 Bn 1.35 Bn -4.79 Bn
5 Vertex Pharmaceuticals 122.09 Bn 114.84 Bn 2.59 Bn -7.25 Bn
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn -8.75 Bn
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.99 Bn 50.80 Bn 1.41 Bn -5.18 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn -3.01 Bn
10 Adlai Nortye 1.19 Bn 1.18 Bn - -8.06 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -8.06 Mn
Jun 30, 2025 -44.15 Mn
Dec 31, 2024 -60.91 Mn
Jun 30, 2024 -97.99 Mn
Dec 31, 2023 -91.50 Mn
Dec 31, 2022 -64.05 Mn